SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-09-062565
Filing Date
2009-12-01
Accepted
2009-12-01 12:47:34
Documents
1
Period of Report
2009-12-01

Document Format Files

Seq Description Document Type Size
1 v167949_6k.htm 6-K 7638917
  Complete submission text file 0001144204-09-062565.txt   7640618
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 091214254
SIC: 2834 Pharmaceutical Preparations